Nexus Hit With Nasdaq Delisting Determination; Appeal Due November 18
NXAT is trading near its 52-week low of $0.3 (3.5% above the low) on light trading volume (0.2× avg).
Summary
Nexus received a Nasdaq Staff Delisting Determination on November 11, 2026 after 30 straight days below $1.00, and the August 3 1-for-30 reverse split blocks the usual 180-day cure period. The company plans to appeal by November 18, 2026; without it, trading suspends November 20, 2026.
Key Events · Legal and Risk Events · NXAT
-
Nasdaq Staff Delisting Determination
Nasdaq notified Nexus on November 11, 2026 that its ordinary shares fail the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2), with the closing bid below $1.00 for 30 consecutive business days from September 30 through November 10, 2026.
-
Reverse Split Blocks Cure Period
Because Nexus effected a 1-for-30 reverse stock split on August 3, 2026, it is not eligible for the customary 180-calendar-day compliance period under Rule 5810(c)(3)(A)(iv).
-
November 18 Appeal Deadline
The company must request a hearing by November 18, 2026 to stay the suspension; otherwise trading in the ordinary shares and NXATW warrants halts at the open on November 20, 2026 and Nasdaq files a Form 25-NSE.
-
Warrants Also Face Delisting
The warrants are subject to delisting under Rule 5560(a), which requires the underlying ordinary shares to remain listed on Nasdaq.
Analysis · NXAT · Trade & Services
Nasdaq has moved to delist Nexus because its shares traded below $1.00 for 30 straight business days, and the 1-for-30 reverse split completed August 3, 2026 disqualifies the company from the usual 180-day cure window. That makes this a hard deadline rather than a warning: the appeal must be filed by November 18, 2026, or trading in both the ordinary shares and the NXATW warrants is suspended at the open on November 20, 2026 and Nasdaq files a Form 25-NSE to strike the securities from listing. A timely hearing request stays the suspension, but the company offers no assurance it wins the appeal or regains compliance. For a stock already trading near its 52-week low, losing the Nasdaq listing would push the shares to OTC quotation, sharply reducing liquidity and cutting off access to the registered offering capacity the company has been relying on for cash.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NXAT was trading at $0.31 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $841.3K. The 52-week trading range was $0.30 to $57.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.